The search for the MEN1 gene

Journal of Internal Medicine

Volumn 243, Issue 6, 1998, Pages 441-446

  Lemmes, I ^a   Van De Ven, W J M ^a   Kas, K ^a   Zhang, C X ^b,c   Giraud, S ^b   Wautot, V ^b   Buisson, N ^b   Pugeat, M ^d   Peix, J L ^f   Caldener, A ^c,f   Parente, F ^g   Quincey, D ⁱ   Courseaux, A ^g   Carle, G F ^g   Gaudray, P ^g,j   De Wit, M J ^k   Lips, C J M ^h   Hoppener J W M ^d,j   Khodaei, S ^f   Grant, A L ^f   Weber, G ^f   Teh, B T ^g   Farnebo, F ^g   Kytola S ^c,i   Grimmond, S ^h   Phelan, C ^g   Larsson, C ^g   Bassett, J H D ^e,i   Forbes, S A ^e,i   Pannett, A A J ^e,i   Thakker, R V ⁱ   more..

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Hopital de l'Antiquaille   (France)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ MEDICAL RESEARCH COUNCIL   (United Kingdom)

^j CNRS   (France)

^k NONE

more..

Author keywords

Cloning; Multiple endocrine neoplasia type 1; Mutation; Tumour suppressor gene

Indexed keywords

GLYCOGEN PHOSPHORYLASE; PROTEIN; SUPPRESSOR CANDIDATE GENE 2 PROTEIN; UNCLASSIFIED DRUG;

CHROMOSOME 11Q; CONFERENCE PAPER; GENE MAPPING; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CLONING, MOLECULAR; EUROPE; GENES, TUMOR SUPPRESSOR; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION;

EID: 7144259735     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00347.x     Document Type: Conference Paper

References (33)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16: 363-71.
2. Shows TB, Alders M, Bennett S, Burbee D, Cartwright P, Chandrasekharappa P et al. Report of the fifth international workshop on human chromosome 11 mapping (1995). Cytogenetics Cell Genetics 1996; 74: 1-56.
3. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Quart J Med 1996; 89: 653-69.
4. The European Consortium on MEN1. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1). Human Genet 1998; 100: 657-65.
5. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-7.
6. The European Consortium on MEN1. Identification of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene. Hum Mol Genet 1997; 6: 1177-83.
7. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85-7.
8. Bale SJ, Bale AE, Stewart K, Dachowski L, McBride OW, Glaser T et al. Linkage analysis of multiple endocrine neoplasia type 1 with 1NT2 and other markers on chromosome 11. Genomics 1989; 4: 320-2.
9. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989; 321: 218-24.
10. Byström C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B et al. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 1990; 87: 1968-72.
11. Lubensky I, Debelenko L, Zhuang Z, Emmert-Buck M, Dong Q, Chandrasekharappa S et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 1996; 56: 5272-8.
12. Charmley P, Nguyen J, Wei S, Gatti RA, Genetic linkage analysis and homology relationships of genes located on human chromosome 11q. Genomics 1991; 10: 608-17.
13. Julier C, Nakamura Y, Lathrop M, O'Connell P, Leppert M, Litt M et al. A detailed genetic map of the long arm of chromosome 11. Genomics 1990; 7: 335-45.
14. Litt M, Kramer P, Hauge X, Weber J, Wang Z, Wilkie P et al. A microsatelite-based index map of human chromosome 11. Hum Mol Genet 1993; 2: 909-13.
15. Janson M, Larsson C, Werelius B, Jones C, Glaser T, Nakamura Y et al. Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus. Proc Natl Acad Sci USA 1991; 88: 10609-13.
16. Szepetowski P, Simon MP, Grosgeorge J, Huebner K, Bastard C, Evans GA et al. Localization of 11q13 loci with respect to regional chromosomal breakpoints. Genomics 1992; 12: 738-44.
17. Tanigami A, Tokino T, Takita K, Takiguchi S, Nakamura Y. A 14-Mb physical map of the region at chromosome 11q13 harboring the MEN1 locus and the tumor amplicon region. Genomics 1992; 13: 16-20.
18. Richard CW, Withers DA, Meeker TC, Maurer S, Evans GA, Myers RM et al. A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci. Am J Hum Genet 1991; 49: 1189-96.
19. Kas K, Weber G, Meeregaert J, Michiels L, Sandelin K, Skogseid B et al. Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1993; 2: 349-53.
20. Grimmond S, Weber G, Larsson C, Walters M, Teh B, Shepherd J et al. Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1. Hum Genet 1995; 95: 455-8.
21. Pang JT, Lloyd SE, Wooding C, Farren B, Pottinger B, Harding B et al. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13. and exclusion of μ-calpain as the multiple endocrine neoplasia type 1 gene. Hum Genet 1996; 97: 732-41.
22. Weber G, Grimmond S, Lagercrantz J, Friedman E, Phelan C, Carson E et al. Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1. Hum Genet 1997; 99: 130-2.
23. de Wit MJ, Landsvater RM, Sinke RJ, Geurts van Kessel A, Lips CJ, Höppener JW. Exclusion of the phosphatidylinositol-specific phospholipase C beta 3 (PLC beta 3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Genet 1997; 99: 133-7.
24. Landsvater RM, de Wit MJ, Peterson LF, Sinke RJ, Geurts van Kessel A, Lips CJ et al. Exclusion of the nuclear factor-kappa B3 (REL A) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene. Biochem Mol Med 1997; 60: 76-9.
25. Lloyd SE, Pang JT, Pearce SH, Leigh SE, Thakker RV. Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN 1). Hum Genet 1997; 99: 585-9.
26. Lassam NJ, Lin Z, Shennan MG, Courseaux A, Teh BT, Gaudray P et al. Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility gene. Hum Genet 1997; 99: 776-80.
27. The European Consortium on MEN1. Mapping of the B56b subunit of Protein Phosphatase 2A (PP2A) to a 0.5 Mb region of chromosome 11q13 and its exclusion as a candidate gene for Multiple Endocrine Neoplasia Type 1 (MEN1). Hum Genet 1998; 100: 481-5.
28. The European Consortium on MEN1. Definition of the minimal MEN 1 candidate area based on a 5 Mb integrated map of proximal 11q13. Genomics 1996; 37: 354-65.
29. The European Consortium on MEN1. Construction of a 1.2 Mb sequence-ready contig of chromosome 11q13 encompassing the Multiple Endocrine Neoplasia Type 1 (MEN1) gene. Genomics 1997; 44: 94-100.
30. Wood TF, Srivatsan ES, Chakrabarti R, Ma GC, Kuan N, Samara GJ et al. A 1.5-Megabase physical map encompassing the Multiple Endocrine Neoplasia Type-1 (MEN1) locus on chromosome 11q13. Genomics 1996; 38: 166-73.
31. Pook MA, Thakrar R, Pottinger B, Harding B, Porteous D, van Heyningen V et al. Eagl and Notl linking clones from human chromosomes 11 and Xp. Hum Genet 1996; 97: 742-9.
32. Larsson C, Weber G, Kvanta E, Lewis K, Janson M, Jones C et al. Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus. Hum Genet 1992; 89: 187-93.
33. Grimmond S, Lagerkrantz J, Drinkwater C, Silins G, Townson S, Pollock P et al. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 1996; 6: 122-9.